Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. (öffnet neues Fenster)

de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, de Jonge E, Gesink-van der Veer BJ.

Quelle‎: Intensive Care Med 2013;39(11):2011-9.

Indiziert‎: PubMed 23995984

DOI‎: 10.1007/s00134-013-3085-7

https://www.ncbi.nlm.nih.gov/pubmed/23995984 (öffnet neues Fenster)

Pediatric red blood cell transfusions increase resource use. (öffnet neues Fenster)

Goodman AM, Pollack MM, Patel KM, Luban NL.

Quelle‎: J Pediatr 2003;142(2):123-7.

Indiziert‎: PubMed 12584531

DOI‎: 10.1067/mpd.2003.14

https://www.ncbi.nlm.nih.gov/pubmed/12584531 (öffnet neues Fenster)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (öffnet neues Fenster)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Quelle‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indiziert‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (öffnet neues Fenster)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (öffnet neues Fenster)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Quelle‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indiziert‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (öffnet neues Fenster)

Economic evaluation of cell salvage in pediatric surgery. (öffnet neues Fenster)

Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM.

Quelle‎: Paediatr Anaesth 2013;23(11):1027-34.

Indiziert‎: PubMed 23952976

DOI‎: 10.1111/pan.12233

https://www.ncbi.nlm.nih.gov/pubmed/23952976 (öffnet neues Fenster)